MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

Search

InflaRx NV

Închisă

0.91 -8.08

Rezumat

Modificarea prețului

24h

Curent

Minim

0.91

Maxim

1.01

Indicatori cheie

By Trading Economics

Venit

12M

-5.1M

Vânzări

-124K

-423

EPS

-0.08

Marjă de profit

1,208,456.738

Angajați

74

EBITDA

12M

-5M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+659.41% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

-13M

68M

Deschiderea anterioară

8.99

Închiderea anterioară

0.91

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

InflaRx NV Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 apr. 2025, 22:42 UTC

Principalele dinamici ale pieței

Peabody Energy Shares Climb on Trump Executive Orders Boosting Coal Industry

8 apr. 2025, 22:35 UTC

Câștiguri
Principalele dinamici ale pieței

Cal-Maine Foods Shares Fall As Justice Dept Probes Egg Prices

8 apr. 2025, 21:30 UTC

Câștiguri

Cal-Maine Foods Cooperating With Justice Dept Probe Into Egg Price Increases -- Update

8 apr. 2025, 21:21 UTC

Câștiguri

Cal-Maine Foods Cooperating With Justice Dept Probe into Egg Price Increases

9 apr. 2025, 00:00 UTC

Top știri

Trump's Tariffs Put Fed Chair Powell in a 'No-Win Situation' -- WSJ

8 apr. 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 apr. 2025, 23:45 UTC

Market Talk

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

8 apr. 2025, 23:43 UTC

Market Talk

Lithium Oversupply Weighs on Price Outlook -- Market Talk

8 apr. 2025, 23:43 UTC

Achiziții, Fuziuni, Preluări

Woolworths' Rivals Have Other Options to Source Ready Meals, ACCC Says

8 apr. 2025, 23:42 UTC

Market Talk

Gold Falls on Possible Unwinding of Long Positions to Raise Cash -- Market Talk

8 apr. 2025, 23:42 UTC

Achiziții, Fuziuni, Preluări

Beak & Johnston Makes Ready Meals, Pastries for Wholesale, Retail

8 apr. 2025, 23:41 UTC

Achiziții, Fuziuni, Preluări

Woolworths' Acquisition Unlikely to Have Substantial Anti-Competitive Effect, ACCC Says

8 apr. 2025, 23:40 UTC

Achiziții, Fuziuni, Preluări

Australian Competition and Consumer Commission: Will Not Oppose Transaction

8 apr. 2025, 23:39 UTC

Achiziții, Fuziuni, Preluări

Australian Competition Regulator to Allow Woolworths' Acquisition of Beak & Johnston

8 apr. 2025, 23:21 UTC

Achiziții, Fuziuni, Preluări

U.S. Steel: $75 per Shr That the Ancora 'Plan' Proposes Is Really an Unrealistic, Distant Future Value Pipedream Rooted Firmly in Fiction >X

8 apr. 2025, 23:21 UTC

Achiziții, Fuziuni, Preluări

U.S. Steel: Stockholders Should Be Very Skeptical of Ancora's 'Plan' or That Their Nominees Could or Would Vigorously Fight for the Nippon Steel Deal >X

8 apr. 2025, 21:26 UTC

Top știri

When Coffee Mate Made a 'White Lotus' Piña Colada Creamer, It Had No Idea How the Season Would End -- WSJ

8 apr. 2025, 21:26 UTC

Câștiguri

Pfizer Stock's Fall to '97 Level Lifts Yield Near 8%. Dividend Looks Safe. -- Barrons.com

8 apr. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

Peabody Energy: Remains in Conversation With Anglo Amer to Better Understand Impacts of Event, Preserving All Rights and Protections Under Purchase Agreements >BTU

8 apr. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

Peabody Energy: Following Ignition Event Last Week at Anglo Amer's Moranbah North Mine, Reviewing Options Related to Acquisition of Steelmaking Coal Assets From Anglo Amer >BTU

8 apr. 2025, 21:06 UTC

Top știri

Stocks Are in Turmoil, but Treasury Yields Are Stubbornly High -- Update

8 apr. 2025, 20:50 UTC

Top știri

Harley-Davidson Seeks New CEO, Facing Sales Slump and Tariffs -- 3rd Update

8 apr. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

8 apr. 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8 apr. 2025, 20:49 UTC

Top știri

Vanguard Cuts Forecast for U.S. Economy. Tariffs Have Us 'Dancing With Recession.' -- Barrons.com

8 apr. 2025, 20:40 UTC

Câștiguri

BYD Stock Soars. It's Catching Up to Tesla in Yet Another Way. -- Barrons.com

8 apr. 2025, 20:28 UTC

Câștiguri

Sandstorm Gold: Will Release 1Q Results on May 6 After Markets Close >SSL.T

8 apr. 2025, 20:28 UTC

Câștiguri

Sandstorm Gold: During Three Mos Ended March 31, Realized Record Preliminary Revenue of $50.1M (20,316 Attributable Gold Equivalent Ounces and $42.8M in Rev for the Comparable Period in 2024) >SSL.T

8 apr. 2025, 20:28 UTC

Câștiguri

Sandstorm Gold: Record Preliminary Total Sales, Royalties, Income From Other Interests of $54.1M for Three Mos Ended March 31 ($42.8M in Total Sales, Royalties, Income From Other Interests for Comparable Period in 2024) >SSL.T

8 apr. 2025, 20:28 UTC

Câștiguri

Sandstorm Gold: During Three Mos Ended March 31, Sold Approximately 18,500 Attributable Gold Equivalent Ounces >SSL.T

Comparație

Modificare preț

InflaRx NV Așteptări

Obiectiv de preț

By TipRanks

659.41% sus

Prognoză pe 12 luni

Medie 7.67 USD  659.41%

Maxim 10 USD

Minim 5 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruInflaRx NV - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

4 ratings

3

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

1.01 / 1.05Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Very Strong Bearish Evidence

Termen lung

Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre InflaRx NV

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company develops INF904, an oral, small molecule drug candidate for the chronic inflammatory and autoimmune diseases; IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases; and Gohibic (vilobelimab) for the treatment of COVID-19 and broader ARDS. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany.